CpG methylation is maintained in human cancer cells lacking DNMT1

Hypermethylation is associated with the silencing of tumour susceptibility genes in several forms of cancer 1 , 2 ; however, the mechanisms responsible for this aberrant methylation are poorly understood 3 , 4 . The prototypic DNA methyltransferase, DNMT1, has been widely assumed to be responsible f...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Nature (London) Jg. 404; H. 6781; S. 1003 - 1007
Hauptverfasser:	Rhee, Ina, Jair, Kam-Wing, Yen, Ray-Whay Chiu, Lengauer, Christoph, Herman, James G., Kinzler, Kenneth W., Vogelstein, Bert, Baylin, Stephen B., Schuebel, Kornel E.
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	London Nature Publishing Group UK 27.04.2000 Nature Publishing Nature Publishing Group
Schlagworte:	5-Methylcytosine Biological and medical sciences Blotting, Southern Cancer Colorectal carcinoma Cytosine - analogs & derivatives Cytosine - metabolism Deoxyribonucleic acid DNA DNA (Cytosine-5-)-Methyltransferase 1 DNA (Cytosine-5-)-Methyltransferases - deficiency DNA (Cytosine-5-)-Methyltransferases - metabolism DNA Methylation DNMT1 gene Gene Silencing General aspects Genes Genes, p16 Humanities and Social Sciences Humans INK4a gene letter Medical sciences Methylation multidisciplinary Pathology Science Science (multidisciplinary) Tumor Cells, Cultured Tumors Rectal disease Carcinoma Reaction specificity CpG island Carcinogenesis Genetic determinism Gene GC rich sequence Established cell line Intestinal disease Colon Tumor cell Tumor suppressor gene Human Nucleotide sequence Enzyme Transferases Malignant tumor Colonic disease Gene silencing Methyltransferases Rectum Epigenetics Digestive diseases Hypermethylation Genome Methylation
ISSN:	0028-0836, 1476-4687
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!